Lablytica is a proud sponsor of the 17th Symposium on Pharmacokinetics and Drug Metabolism

nov 7, 2024

Lablytica is a proud sponsor of the 17th Symposium on Pharmacokinetics and Drug Metabolism arranged by Läkemedelsakademin in Mölndal on November 12-13, 2024

The overall aim of the symposium is to highlight hot topics within the field of Pharmacokinetics, Drug Metabolism, Pharmacokinetics/Pharmacodynamics, ADME, and Clinical Pharmacology.

As a laboratory performing bioanalysis for pharmacokinetic and pharmacodynamic studies, Lablytica is passionate about continuing the conversations around these topics in Sweden. We look forward to providing input regarding the new ICH M10 bioanalysis guidelines.

David Pekar, CEO Lablytica will be present. Make sure to reach out for a first contact, to find out what we can do for you within bioanalysis.

Hope to see you there!

Read more and register https://lnkd.in/dTjPzpkY

 

You might also like

CTR launches podcast together with SwedenBIO

CTR launches podcast together with SwedenBIO

apr 11, 2022

The first episode of the podcast Idé till patient (Idea to patient) will be released on April 12. The podcast series is a co-production between the companies within the CTR-group and SwedenBIO. The series comprises six episodes where invited guests from the pharma...

CTR acquires preclinical toxicology company

CTR acquires preclinical toxicology company

apr 6, 2021

Center for Translational Research Sweden AB (CTR) acquires Toxicology Knowledge Team Sweden AB (TKT) further strengthening the CTR group with optimised toxicological support. From April 1, TKT is a fully owned subsidiary to the holding company CTR. The activities at...

CTR launches podcast together with SwedenBIO

apr 11, 2022

The first episode of the podcast Idé till patient (Idea to patient) will be released on April 12. The podcast series is a co-production between the companies within the CTR-group and SwedenBIO. The series comprises six episodes where invited guests from the pharma...

CTR acquires preclinical toxicology company

apr 6, 2021

Center for Translational Research Sweden AB (CTR) acquires Toxicology Knowledge Team Sweden AB (TKT) further strengthening the CTR group with optimised toxicological support. From April 1, TKT is a fully owned subsidiary to the holding company CTR. The activities at...

New statement of OECD GLP compliance

mar 22, 2021

Happy and proud to share that Lablytica has just received their new statement of OECD GLP compliance for Analytical and Clinical Chemistry testing (8) from SWEDACs inspection on the 10 November 2020....

David Pekar becomes CEO at Lablytica

nov 1, 2020

Lablytica Life Science AB started in November 2019 when Recipharm’s GLP bioanalysis business was divested to Center for Translational Research AB (CTR). David Pekar has since then been the Site Manager and Chief Scientific Officer at Lablytica. As announced by CTR,...